These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 12761254

  • 21. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
    Moon JA, Kim HT, Cho IS, Sheen YY, Kim DK.
    Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
    [Abstract] [Full Text] [Related]

  • 22. Non-viral Smad7 gene delivery and attenuation of postoperative peritoneal adhesion in an experimental model.
    Guo H, Leung JC, Cheung JS, Chan LY, Wu EX, Lai KN.
    Br J Surg; 2009 Nov; 96(11):1323-35. PubMed ID: 19847872
    [Abstract] [Full Text] [Related]

  • 23. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
    Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A.
    J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
    [Abstract] [Full Text] [Related]

  • 24. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy.
    Liu Z, Huang XR, Chen HY, Penninger JM, Lan HY.
    Lab Invest; 2012 May; 92(5):650-61. PubMed ID: 22330342
    [Abstract] [Full Text] [Related]

  • 25. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
    Yang F, Chung AC, Huang XR, Lan HY.
    Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
    [Abstract] [Full Text] [Related]

  • 26. Saroglitazar attenuates renal fibrosis induced by unilateral ureteral obstruction via inhibiting TGF-β/Smad signaling pathway.
    Makled MN, El-Kashef DH.
    Life Sci; 2020 Jul 15; 253():117729. PubMed ID: 32348836
    [Abstract] [Full Text] [Related]

  • 27. Arkadia-Smad7-mediated positive regulation of TGF-beta signaling in a rat model of tubulointerstitial fibrosis.
    Liu FY, Li XZ, Peng YM, Liu H, Liu YH.
    Am J Nephrol; 2007 Jul 15; 27(2):176-83. PubMed ID: 17347560
    [Abstract] [Full Text] [Related]

  • 28. Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.
    Sakairi T, Hiromura K, Takahashi S, Hamatani H, Takeuchi S, Tomioka M, Maeshima A, Kuroiwa T, Nojima Y.
    Nephrology (Carlton); 2011 Jan 15; 16(1):76-86. PubMed ID: 21175982
    [Abstract] [Full Text] [Related]

  • 29. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.
    Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM, Sheppard D, Fogo AB.
    Am J Pathol; 2003 Oct 15; 163(4):1261-73. PubMed ID: 14507636
    [Abstract] [Full Text] [Related]

  • 30. You-gui Pill ameliorates renal tubulointerstitial fibrosis via inhibition of TGF-β/Smad signaling pathway.
    Wang L, Cao AL, Chi YF, Ju ZC, Yin PH, Zhang XM, Peng W.
    J Ethnopharmacol; 2015 Jul 01; 169():229-38. PubMed ID: 25922264
    [Abstract] [Full Text] [Related]

  • 31. [Effects of curcumin on the epithelial mesenchymal transition and TGF-beta/Smads signaling pathway in unilateral ureteral obstruction rats].
    Li Y, Chen ZQ, Li YD.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Sep 01; 31(9):1224-8. PubMed ID: 22013801
    [Abstract] [Full Text] [Related]

  • 32. The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis.
    Lee J, Hwang I, Lee JH, Lee HW, Jeong LS, Ha H.
    Am J Pathol; 2013 Nov 01; 183(5):1488-1497. PubMed ID: 24001475
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Role of TGF-beta signaling in extracellular matrix production under high glucose conditions.
    Li JH, Huang XR, Zhu HJ, Johnson R, Lan HY.
    Kidney Int; 2003 Jun 01; 63(6):2010-9. PubMed ID: 12753288
    [Abstract] [Full Text] [Related]

  • 38. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W, Koka V, Lan HY.
    Nephrology (Carlton); 2005 Feb 01; 10(1):48-56. PubMed ID: 15705182
    [Abstract] [Full Text] [Related]

  • 39. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
    Xiao Z, Zhang J, Peng X, Dong Y, Jia L, Li H, Du J.
    Int J Biochem Cell Biol; 2014 Oct 01; 55():65-71. PubMed ID: 25150830
    [Abstract] [Full Text] [Related]

  • 40. Gene transfer of Smad7 using electroporation of adenovirus prevents renal fibrosis in post-obstructed kidney.
    Terada Y, Hanada S, Nakao A, Kuwahara M, Sasaki S, Marumo F.
    Kidney Int; 2002 Jan 01; 61(1 Suppl):S94-8. PubMed ID: 11841620
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.